提振信心!晶泰控股两日耗资超1100万港元回购154万股

格隆汇
Sep 04
基于对未来发展前景及公司长期投资价值的信心,AI制药与材料科学科技公司晶泰控股(2228.HK)近日持续启动股份回购。根据公司披露的最新公告,晶泰控股分别于2026年9月2日斥资987.1万港元回购137.5万股,以及于9月3日斥资118.53万港元回购16.5万股。短短两日内,公司共计耗资1105.63万港元,累计回购154万股普通股。分析指出,随着AI在生命科学与新材料领域的渗透率加速提升,晶泰控股在资本市场的回购举措将持续强化投资者对其基本面筑底回升的预期,推动长期价值重估。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10